Annotation Detail
Information
- Associated Genes
- BRCA1
- Associated Variants
-
BRCA1 LOSS-OF-FUNCTION
BRCA1 LOSS-OF-FUNCTION - Associated Disease
- ovarian carcinoma
- Source Database
- CIViC Evidence
- Description
- In a study of ovarian carcinomas, 87% of tumors with somatic BRCA1/2 mutations were platinum sensitive, whereas only 60% of tumors with non-BRCA1/2 mutations were platinum sensitive (N=38; N=158; P=0.002). Sensitivity to platinum was defined by maintenance of complete response greater than 6 months post platinum-based therapy.
- Variant Origin
- somatic
- Variant Origin
- Somatic
- Evidence URL
- https://civic.genome.wustl.edu/links/evidence_items/1531
- Gene URL
- https://civic.genome.wustl.edu/links/genes/6
- Variant URL
- https://civic.genome.wustl.edu/links/variants/185
- Rating
- 3
- Evidence Type
- Predictive
- Disease
- Ovarian Carcinoma
- Evidence Direction
- Supports
- Drug
- Platinum Compound
- Evidence Level
- B
- Clinical Significance
- Sensitivity/Response
- Pubmed
- 24240112
Drugs
| Drug Name | Sensitivity | Supported |
|---|---|---|
| Platinum Compound | Sensitivity | true |